Vifor Pharma AG (XSWX:VIFN) Accounts Payable & Accrued Expense : CHF263 Mil (As of Dec. 2021)

View and export this data going back to 2003. Start your Free Trial

What is Vifor Pharma AG Accounts Payable & Accrued Expense?

Vifor Pharma AG's quarterly accounts payable & accrued expense declined from Dec. 2020 (CHF265 Mil) to Jun. 2021 (CHF231 Mil) but then increased from Jun. 2021 (CHF231 Mil) to Dec. 2021 (CHF263 Mil).

Vifor Pharma AG's annual accounts payable & accrued expense increased from Dec. 2019 (CHF197 Mil) to Dec. 2020 (CHF265 Mil) but then declined from Dec. 2020 (CHF265 Mil) to Dec. 2021 (CHF263 Mil).

Vifor Pharma AG Accounts Payable & Accrued Expense Historical Data

The historical data trend for Vifor Pharma AG's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG Accounts Payable & Accrued Expense Chart

Vifor Pharma AG Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

224.50

237.00

197.20

264.60

262.60

Vifor Pharma AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															197.20	218.60	264.60	230.90	262.60

Vifor Pharma AG Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Vifor Pharma AG (XSWX:VIFN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (XSWX:VIFN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rechenstrasse 37, Saint Gallen, CHE, 9014

Website

https://www.viforpharma.com

Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (XSWX:VIFN) Headlines

No Headlines